Initial clinical experience with the VentrAssist left ventricular assist device: the pilot trial.

BACKGROUND The VentrAssist (VA) is a novel, continuous flow left ventricular assist device (LVAD). The purpose of this trial was to investigate the safety and efficacy of the VA in elderly patients with end-stage heart failure. METHODS In this prospective trial, patients requiring circulatory support either as destination therapy (DT) or as a bridge to transplant (BTT) were implanted with a VA device. RESULTS Between June 2003 and August 2006, 9 elderly patients (mean age 65 years) were implanted. The median support time was 454 (range 73 to 977) days for the DT and 35 (range 26 to 508) days for the BTT cohort. All patients survived implantation; 30-day mortality was 22% (n = 2). The adverse event profile was encouraging, with no embolic neurologic events and minimal sepsis. Cumulative trial support time was 7.3 patient-years. CONCLUSIONS The VentrAssist shows promise as a safe and reliable "third-generation" VAD. Having demonstrated potential as a DT and prolonged BTT device, extended clinical trials are warranted.

[1]  Robert L. Kormos,et al.  Mechanical Circulatory Support device database of the International Society for Heart and Lung Transplantation: first annual report--2003. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  S. Yusuf,et al.  A lifetime of prevention: the case of heart failure. , 2002, Circulation.

[3]  P. McCarthy,et al.  Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. , 2001, The Annals of thoracic surgery.

[4]  F. Oliva,et al.  Bridge to transplantation with the MicroMed DeBakey ventricular assist device axial pump: a single centre report , 2006, Journal of cardiovascular medicine.

[5]  Natalie L James,et al.  Evaluation of hemolysis in the VentrAssist implantable rotary blood pump. , 2003, Artificial organs.

[6]  Stephen Westaby,et al.  Initial Clinical Experience With the Jarvik 2000 Implantable Axial-Flow Left Ventricular Assist System , 2002, Circulation.

[7]  Markus J. Wilhelm,et al.  Treatment of Thrombus Formation Associated With the MicroMed DeBakey VAD Using Recombinant Tissue Plasminogen Activator , 2002, Circulation.

[8]  Daniel Burkhoff,et al.  Mechanical Device–Based Methods of Managing and Treating Heart Failure , 2005, Circulation.

[9]  Kiyotaka Fukamachi,et al.  Predictors of Severe Right Ventricular Failure After Implantable Left Ventricular Assist Device Insertion: Analysis of 245 Patients , 2002, Circulation.

[10]  G Laufer,et al.  First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. , 2000, Circulation.

[11]  D. Goldstein,et al.  Worldwide Experience With the MicroMed DeBakey Ventricular Assist Device® as a Bridge to Transplantation , 2003, Circulation.

[12]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[13]  L. Miller,et al.  Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  John Woodard,et al.  VentrAssist left ventricular assist device: clinical trial results and Clinical Development Plan update. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[16]  S. Stewart,et al.  Uncovering a hidden epidemic: a study of the current burden of heart failure in Australia. , 2004, Heart, lung & circulation.

[17]  Yoshifumi Naka,et al.  Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  Effect of carvedilol on survival in severe chronic heart failure. , 2001 .

[19]  R. Kormos,et al.  Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: Third Annual Report—2005⁎ ⁎All figures and tables from this report, and a more comprehensive set of ISHLT registry slides are available at www.ishlt.org/registries/ , 2005 .

[20]  Satoshi Saito,et al.  Circulatory Support for Long-Term Treatment of Heart Failure: Experience With an Intraventricular Continuous Flow Pump , 2002, Circulation.

[21]  David Kaye,et al.  First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  Christoph Schmidt,et al.  Long-term support of 9 patients with the DeBakey VAD for more than 200 days. , 2005, The Journal of thoracic and cardiovascular surgery.

[23]  W. Abhayaratna,et al.  Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study , 2006, The Medical journal of Australia.

[24]  G. Edwards,et al.  Implantation of the VentrAssist Implantable Rotary Blood Pump in Sheep , 2003, ASAIO journal.